Ember Therapeutics, Inc. announced the appointment of Jasbir Seehra, Ph.D., to chief scientific officer; also, Jeff Saunders, Ph.D., joins the company as vice president, small molecule drug discovery. Dr. Seehra has served as an advisor on the company's scientific advisory board since the company's launch last year. Prior to joining in the company Therapeutics, Dr. Saunders served as the vice president of chemistry at Agios Pharmaceuticals. Dr. Seehra served as chief scientific officer of Acceleron Pharma, Inc. He has also served as vice president of biological chemistry at Wyeth and led the small molecule lead discovery effort at Genetics Institute, Inc.